MedPath

Biomarin International Limited

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

36

CIMA_AEMPS:11
CANADA:8
EMA:7
+1 more agencies

Drug Approvals

Elosulfase Alfa Injection

Product Name
唯铭赞
Approval Number
S20190024
Approval Date
May 21, 2019
NMPA

Sapropterin Dihydrochloride Tablets

Product Name
科望
Approval Number
H20181141
Approval Date
Mar 22, 2018
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.